PROTEMBIS
ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR. The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures. Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity ... of TAVR. Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
PROTEMBIS
Social Links:
Industry:
Emergency Medicine Health Care Life Science Medical Device Personal Health
Founded:
2013-01-01
Address:
Aachen, Nordrhein-Westfalen, Germany
Country:
Germany
Website Url:
http://www.protembis.com
Total Employee:
1+
Status:
Active
Contact:
+49 (0) 241 9903 3622
Email Addresses:
[email protected]
Total Funding:
10 M USD
Technology used in webpage:
SPF LetsEncrypt IPv6 Ubuntu Smart App Banner Nextcloud Strato Strato DNS
Similar Organizations
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
COMPASS Pathways
Compass Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health.
Enable Injections
Enable Injections designs and produces on-body delivery systems that allow patients to self-administer large amounts of medication.
Current Employees Featured
Founder
Investors List
TechVision Fonds
TechVision Fonds investment in Series A - Protembis
Abiomed
Abiomed investment in Series A - Protembis
coparion
coparion investment in Series A - Protembis
IFB Innovationsstarter
IFB Innovationsstarter investment in Seed Round - Protembis
Official Site Inspections
http://www.protembis.com
- Host name: w9e.rzone.de
- IP address: 81.169.145.158
- Location: Berlin Germany
- Latitude: 52.5174
- Longitude: 13.3985
- Timezone: Europe/Berlin
- Postal: 12529
